文献速递消化内镜消化道肿瘤与早癌

近端5-9mm增生性息肉患者异时性大锯齿状息肉风险增加:新罕布什尔结肠镜登记数据

Increased risk of metachronous large serrated polyps in individuals with 5- to 9-mm proximal hyperplastic polyps: data from the New Hampshire Colonoscopy Registry.
PubMed 文献 · Gastrointest Endosc · 2020-04-26

基于新罕布什尔结肠镜登记(NHCR)8560例成人数据,指数结肠镜切除至少1枚息肉且≥12个月后复查者纳入分析。近端5-9mm增生性息肉(HP)患者异时性大锯齿状息肉(SP)风险显著高于低风险常规腺瘤患者(OR 4.77,95%CI 2.54-8.94),与指数大HP或任何SSP/TSA者相似(OR 7.63,95%CI 4.78-12.20)。提示此类患者可能需要密切监测。

要点

  • 近端5-9mm HP患者异时性大SP风险较低风险常规腺瘤者升高(OR 4.77)。
  • 该风险与指数大HP或任何SSP/TSA者的风险相似(OR 7.63)。
  • 近端5-9mm HP可能需要密切的监测间隔。

核心结论

  • 指数结肠镜发现乙状结肠近端5-9mm HP的个体,异时性大SP风险增加,与指数大HP或任何SSP/TSA者相似。
  • 这些新数据提示对近端5-9mm HP患者可能适合密切监测间隔。

研究设计与样本

  • 基于新罕布什尔结肠镜登记(NHCR)的队列研究,纳入8560例成人(44.8%女性,平均年龄59.0岁,标准差9.1)。
  • 纳入标准:指数结肠镜至少切除1枚息肉,且指数后≥12个月进行监测检查。
  • 按指数最显著SP进行分层,比较近端5-9mm HP与其他指数发现者的异时性风险。
  • 回归模型调整年龄、性别、BMI、吸烟、既往息肉史、CRC家族史、诊断年份、内镜医师SP检出率及至监测检查月数。

主要发现

  • 近端5-9mm HP患者异时性大SP风险较低风险常规腺瘤者升高(OR 4.77,95%CI 2.54-8.94)。
  • 指数大HP或任何SSP/TSA者异时性大SP风险较低风险常规腺瘤者升高(OR 7.63,95%CI 4.78-12.20)。
  • 近端5-9mm HP患者的异时性大SP风险与指数大HP或任何SSP/TSA者相似。

关键数值与推荐

  • 结局包括异时性大SP(≥1cm)和进展期肿瘤(AN:≥1cm、绒毛成分、高级别上皮内瘤变或结直肠癌)。
  • 指数SP分层包括:近端5-9mm HP、大HP(≥1cm)或任何SSP/TSA、非显著HP(直肠乙状结肠<1cm或结肠任何部位<5mm)、高风险腺瘤(无SP的AA或≥3枚腺瘤)、低风险腺瘤(无SP)。

临床怎么用

  • 对于指数结肠镜发现乙状结肠近端5-9mm HP的患者,应考虑密切的监测间隔。
  • 此类患者的异时性大SP风险与指数大HP或任何SSP/TSA者相似,监测策略可参考高危锯齿状病变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Because data on metachronous risk for patients with index proximal 5- to 9-mm hyperplastic polyps (HPs) are limited, the clinical significance of these polyps is unclear. Conversely, published data suggest that sessile serrated polyps (SSPs), traditional serrated adenomas (TSAs), and large (≥1 cm) HPs are high-risk lesions requiring close surveillance. We used data from the New Hampshire Colonoscopy Registry (NHCR) to examine the risk of metachronous large SPs and advanced neoplasias (ANs) in patients with 5- to 9-mm proximal HPs. METHODS: We included adults with at least 1 polyp resected at index colonoscopy and a surveillance examination 12 months or more after index. Outcomes were risk for metachronous large (≥1 cm) SPs and ANs (≥1 cm, villous elements, high-grade dysplasia, or colorectal cancer [CRC]). Individuals were hierarchically stratified by the most significant index SP. The risks for adults with proximal 5- to 9-mm HPs at index examination were compared with individuals with index findings of large (≥1 cm) HPs or any SSPs or TSAs, nonsignificant HPs (<1 cm in rectosigmoid or <5 mm anywhere in colon), high-risk adenomas (AAs or ≥3 adenomas, no SPs), and low-risk adenomas (no SPs). We present absolute and adjusted risks of metachronous polyps from a regression model that included age, sex, body mass index, smoking, previous polyp history, family history of CRC, year of diagnosis, endoscopist SP detection rates, and months to surveillance examination. RESULTS: A total of 8560 NHCR participants were included (44.8% women; average age, 59.0 years; standard deviation, 9.1). Similar to those with large HPs or any SSPs/TSAs at index examination (odds ratio, 7.63; 95% confidence interval, 4.78-12.20), individuals with proximal 5- to 9-mm HPs had an elevated risk for metachronous large SPs (odds ratio, 4.77; 95% confidence interval, 2.54-8.94) as compared with adults with low-risk conventional adenomas. CONCLUSIONS: NHCR data suggest that similar to adults with large HPs or any SSPs or TSAs at index examination, individuals with index 5- to 9-mm HPs proximal to the sigmoid are at an increased risk for metachronous large SPs. These novel data suggest that close surveillance intervals may be appropriate for patients with 5- to 9-mm proximal HPs.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Anderson JC, Robinson CM, Butterly LF, et al. Increased risk of metachronous large serrated polyps in individuals with 5- to 9-mm proximal hyperplastic polyps: data from the New Hampshire Colonoscopy Registry. Gastrointest Endosc. 2020. PMID: 32348745. doi:10.1016/j.gie.2020.04.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。